These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 549469)

  • 21. Client engagement and change during drug abuse treatment.
    Simpson DD; Joe GW; Rowan-Szal G; Greener J
    J Subst Abuse; 1995; 7(1):117-34. PubMed ID: 7655308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of community structure on during-treatment outcomes of methadone maintenance programs.
    Singh BK
    Int J Addict; 1981 Oct; 16(7):1183-96. PubMed ID: 7327781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Illicit drug use and return to treatment: follow-up study of treatment admissions to DARP during 1969-1971.
    Savage LJ; Simpson DD
    Am J Drug Alcohol Abuse; 1978; 5(1):23-38. PubMed ID: 696704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993.
    Craddock SG; Rounds-Bryant JL; Flynn PM; Hubbard RL
    Am J Drug Alcohol Abuse; 1997 Feb; 23(1):43-59. PubMed ID: 9048146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in opioid addiction careers.
    Marsh KL; Simpson DD
    Am J Drug Alcohol Abuse; 1986; 12(4):309-29. PubMed ID: 3826021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Schütz CG; Rapiti E; Vlahov D; Anthony JC
    Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment services in two national studies of community-based drug abuse treatment programs.
    Etheridge RM; Craddock SG; Dunteman GH; Hubbard RL
    J Subst Abuse; 1995; 7(1):9-26. PubMed ID: 7655314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Description of drug users in treatment: 1971-1972 DARP admissions.
    Simpson DD; Curtis B; Butler MC
    Am J Drug Alcohol Abuse; 1975; 2(1):15-28. PubMed ID: 1190191
    [No Abstract]   [Full Text] [Related]  

  • 30. Methadone maintenance in the small community drug abuse clinic.
    Hebert SW; Lauterbach EC
    Int J Addict; 1983 Aug; 18(6):863-74. PubMed ID: 6629583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of a unique youth drug abuse program: a follow-up study of clients of Straight, Inc.
    Friedman AS; Schwartz R; Utada A
    J Subst Abuse Treat; 1989; 6(4):259-68. PubMed ID: 2593209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of present treatment modalities: research with DARP admissions, 1969-1973.
    Sells SB; Demaree RG; Simpson DD; Joe GW
    Ann N Y Acad Sci; 1978; 311():270-81. PubMed ID: 217292
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between time spent in treatment and client outcomes from therapeutic communities.
    Condelli WS; Hubbard RL
    J Subst Abuse Treat; 1994; 11(1):25-33. PubMed ID: 8201630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-year follow-up of opioid addicts after admission to treatment.
    Simpson DD; Joe GW; Bracy SA
    Arch Gen Psychiatry; 1982 Nov; 39(11):1318-23. PubMed ID: 6982696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic community methods in methadone maintenance (Passages): an open clinical trial.
    De Leon G; Staines GL; Perlis TE; Sacks S; McKendrick K; Hilton R; Brady R
    Drug Alcohol Depend; 1995 Jan; 37(1):45-57. PubMed ID: 7882873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up.
    Camacho LM; Bartholomew NG; Joe GW; Simpson DD
    Drug Alcohol Depend; 1997 Jul; 47(1):11-8. PubMed ID: 9279493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Program factors and treatment outcomes in drug dependence treatment: an examination using meta-analysis.
    Prendergast ML; Podus D; Chang E
    Subst Use Misuse; 2000; 35(12-14):1931-65. PubMed ID: 11138713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L; Keenan E; Elmusharaf K
    BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.